A global scientific strategy to cure hepatitis B

Peter A Revill , Francis V Chisari , Joan M Block , Maura Dandri , Adam J Gehring , Haitao Guo , Jianming Hu , Anna Kramvis , Pietro Lampertico , Harry L A Janssen , Massimo Levrero (1) , Wenhui Li , T Jake Liang , Seng-Gee Lim , Fengmin Lu , M Capucine Penicaud , John E Tavis , Robert Thimme , Fabien Zoulim (1) , Patrick Arbuthnot , Andre Boonstra , Kyong-Mi Chang , Per-Jei Chen , Dieter Glebe , Luca G. Guidotti , Jacques Fellay , Carlo Ferrari , Louis Jansen , Daryl T y Lau , Anna S Lok , Mala K Maini , William Mason , Gail Matthews , Dimitrios Paraskevis , Jörg Petersen , Barbara Rehermann , Eui-Cheol Shin , Alex Thompson , Florian van Bömmel , Fu-Sheng Wang , Koichi Watashi , Hung-Chih Yang , Zhenghong Yuan , Man-Fung Yuen , Timothy Block , Veronica Miller , Ulrike Protzer , Christian Bréchot , Stephen Locarnini , Marion G Peters , Raymond F Schinazi

1 UNICANCER/CRCL - Centre de Recherche en Cancérologie de Lyon

Domaines: Sciences du Vivant [q-bio]

Peter A Revill, Francis V Chisari, Joan M Block, Maura Dandri, Adam J Gehring, et al.. A global scientific strategy to cure hepatitis B. The Lancet Gastroenterology & Hepatology, 2019, 4, pp.545 - 558. ⟨10.1016/S2468-1253(19)30119-0⟩. ⟨hal-03484628⟩